Catalyst Wire Dossier Catalyst Wire Dossier

CXB722

· CeNeRx BioPharma Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CXB722, covering 2009-01-13 to 2009-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Examining the Effects of CXB722 in Neuroendocrine Stress Response in Healthy Males [Phase 1]

See pricing